Issue : 19 November 2007
View all stories from this issue.
Trauma drills help resus skillsSubscription
‘Mock’ trauma drills can easily boost failing child resuscitation skills in A&E, suggests US research.Researchers tested the effect of simple refresher courses at 18 A&E units, which had previously been found lacking in skills including weight-based drug dosing, HbA1c assessments and placement of IVs through the bone – an alternative route for delivering fluids to children ...
Nurses at King’s College Hospital have significantly improved waiting times through use of simple information boards, according to Victoria Hoban.
Day in the Life of an Agency NurseSubscription
Name: Simon DanielsRole: Agency NurseLocation: Staffordshire/Derby/Shropshire/CheshireWage: £14-18 per hour, without pension or sick payPrevious job: Project manager for Child Advocacy International
Day in the Life of a Care Home ManagerSubscription
Name: Nigel JopsonRole: Care Home ManagerLocation: Godalming, SurreyWage: £40K+Previous job: Home Manager for a Southern Cross home
Meet Maria Gough, Walk-in Centre Senior Nurse Practitioner, Harlow
Name: Karen GuyRole: Specialist Nurse, Medicines ManagementLocation: Calderdale and Huddersfield NHS Foundation TrustWage: £28-£37K (Band 7)Previous job: Project Manager within the Medical/Elderly Division and Pharmacy
Day in the life of a Practice NurseSubscription
Name: Joy MilliganRole: Practice NurseLocation: HampshireWage: £23K-£31K (band 6)Previous job: Health Visitor
Trusts to be inspected on race relationsSubscription
A Healthcare Commission review of race equality has found that only 35 out of 394 NHS trusts are fulfilling all of their duties.
ICU outreach reduces mortality in childrenSubscription
A paediatric ICU outreach team reduced mortality rates outside of the unit by 18%, a study has shown.
Hepatitis C combination given green lightSubscription
A new combination therapy for treating hepatitis C has been approved by the European Commission.Schering-Plough’s 48-week standard-dose peginterferon alfa-2b, 1.5 mcg/kg once weekly (ViraferonPeg) and ribavirin, 800-1,400 mg daily (Rebetol) combination therapy has been approved for retreating adult patients whose initial treatment did not result in a sustained response.